Incidence rate, risk factors, and management of Bell’s palsy in the Qurayyat region of Saudi Arabia

Introduction

Bell’s palsy is a common lower motor nerve paralysis of the facial nerve of unknown origin (Eviston et al., 2015). The patient with Bell’s palsy experiences sudden unilateral (rarely bilateral) flaccid paralysis of muscles that control facial expression (Gilden, 2004). The patient is unable to perform facial movements on the affected side, and facial asymmetry is clearly shown with attempted facial movement (Reich, 2017).

The annual incidence rate (1992–1996) was reportedly 20.2 per 100,000 population, according to the UK General Practice Research database (Rowlands et al., 2002). Research studies globally have reported variations in the annual incidence rate (11–50 cases per 100,000) of Bell’s palsy (Hsieh, Wang & Lee, 2013; JI, Prim-Espada & Fernández-García, 2005; Kokotis & Katsavos, 2015; Monini et al., 2010; Yilmaz et al., 2019). The national prevalence of Bell’s palsy in Saudi Arabia is unknown; however, regional incidence/prevalence has been reported in a few studies, such as 5.3 per 100,000 per year (1992–1995) in the Asir region (Al Ghamdi, 1997), 30.4 cases per 100,000 per year (1995–1997) in the Qassim region (Hamid, 1998), 26.3–27.8 cases per 100,000 per year (2011–2012) in the Aljouf region (Jamil et al., 2013), and 26.3 cases per 100,000 per year (2016–2017) in the Arar region (Alanazi et al., 2017).

The cause of Bell’s palsy is idiopathic; however many possible causes have been recognized, such as reactivation of the herpes simplex virus, human immunodeficiency virus, and hepatitis C virus (Greco et al., 2012). Additionally, there are several risk factors associated with Bell’s palsy, including age, pregnancy, epilepsy, obesity, hypertension, diabetes, respiratory tract infection, vaccination (Colella, Orlandi & Cirillo, 2021; Potterton, 2015), and genetic susceptibility due to consanguineous marriages in Saudi Arabia (Middle et al., 2007). The recent increase in the prevalence of diabetes (Elhadd, Al-Amoudi & Alzahrani, 2007), hypertension (Al-Nozha et al., 2007), and obesity (Al-Nozha et al., 2005) in Saudi Arabia increase the risk of Bell’s palsy. In addition, the customary practice of consanguineous marriage increases the risk of autosomal recessive genetic disorders (AbdulAzeez et al., 2019). Therefore, a study is needed to explore the possible impact of increased risk factors and consanguineous marriage on the incidence rate of Bell’s palsy in the Saudi population.

The standard recommended treatment of Bell’s palsy is oral corticosteroids, with limited evidence concerning the additive benefit of antiviral drugs for 10–12 days (Allen & Dunn, 2004; Engström et al., 2008; Heckmann et al., 2019; Salinas et al., 2010). In addition, physiotherapy (Gatidou et al., 2021), acupuncture (Liang et al., 2006), dry needling (Zhang, Wang & He, 2007), taping (Ghous et al., 2018), and neural mobilization techniques (Kashoo, Alqahtani & Ahmad, 2021) have been reported to be beneficial. However, traditional methods of treating Bell’s palsy in Saudi Arabia are still in practice. Two of the common traditional methods for general pain management are the use of herbs (Shaikh, 2021) and cauterization (Aboushanab & AlSanad, 2019). Cauterization for Bell’s palsy is performed by placing a hot iron rod on the back of the neck or between the thumb and index finger (Alsanad et al., 2018). Such traditional methods may result in severe burn injuries and sometimes develop into complicated wounds in cases with pre-existing conditions, such as diabetes (Qureshi et al., 2018).

There is limited literature on the contribution of risk factors and the treatments preferred by the Saudi population following a diagnosis of Bell’s palsy. Therefore, the aim of this study is to determine the incidence rate, possible risk factors, and preferred treatment options for Bell’s palsy in the Saudi population.

Materials & Methods

Study design and setting

The study was a retrospective cross-sectional hospital-based study. The study was carried out in the department of physiotherapy at the Qurayyat General Hospital and King Fahad Hospital. Ethical approval was obtained from the ethical committee of the hospitals in December 2020 prior to the commencement of the study (QGH-EC-16-2020).

The files and medical records of patients diagnosed with Bell’s palsy in Qurayyat General Hospital and King Fahad Hospital were reviewed. A total of 279 patients from the years 2015 through 2020, inclusively, were identified and contacted by email and telephone for participation. If the patient was a minor, the parents were contacted for consent (Fig. 1). The subjects were included in the study if they had been diagnosed with Bell’s palsy by a qualified medical doctor. One subject who was recruited through a community advertisement was assessed by a neurologist at Qurayyat General Hospital.

Results

Among the 171 Bell’s palsy patients participating in the study, most were female (n = 147, 86%). The highest number of patients with Bell’s palsy was among the group aged 21–30 years (n = 76,44.4%), and the lowest was among those aged 1–10 years (n = 11,6.4%). Most were reporting Bell’s palsy for the first time (n = 129, 75.45%), and 10.5% (n = 18) were reporting recurrent Bell’s palsy. A total of 21 (12.3%) participants had been vaccinated with COVID-19 before experiencing Bell’s palsy (Table 1).

A significant number of participants (n = 135,78.9%) reported being exposed to cold air before experiencing Bell’s palsy. A likelihood-ratio test was performed to examine the relation between age group and exposure to cold air before experiencing Bell’s palsy and was found to be significant, χ²(5, n = 171) = 14.92, p = 0.011. The post hoc analysis with Bonferroni correction and adjusted p-value of 0.007 was found to be significant at the p < 0.05 level and revealed that those aged 21–30 years were significantly affected. Sixty-five (38%) participants reported that their parents were cousins, and 20 (11.7%) reported having a familial genetic disorder. There was no significant relationship between consanguinity with gender, onset, and recurrence of Bell’s palsy; however, consanguinity showed a significant relationship with side affected and age group χ²(2, N = 171) = 12.090, p = 0.002; χ²(5, N = 171) = 13.025, p = 0.023 respectively.

The main preferred therapeutic approach was physiotherapy (n = 149, 87.1%), followed by corticosteroids and antiviral drugs (n = 61, 35.7%), acupressure (n = 35, 20.5%), traditional Saudi herb medicine (n = 32, 18.7%), cauterization by hot iron rod (n = 23, 13.5%), supplementary therapy (vitamins and neuro-vitality drugs (n = 2, 1.2%), facial cosmetic surgery (n = 1, 0.6%), and no treatment (n = 1, 0.6%) (Table 2).

Relatively fewer participants had suffered from ear infections (n = 28, 16.4%), diabetes (n = 23, 13.5%), genetic diseases (n = 20, 11.7%), high blood pressure (n = 18, 10.5%), neurological disorder (n = 16, 9.4%), head injury (n = 11, 6.4%), balance problems (n = 10, 5.8%) stroke (n = 3, 1.8%), or heart disease (n = 3, 1.8%) (Fig. 2).

Discussion

This study aimed to determine the incidence rate, risk factors, and preferred treatment among participants with Bell’s palsy residing in the Qurayyat region of Saudi Arabia. According to this study, females were predominantly affected, and a significant number of participants opted for physiotherapy and corticosteroid and antiviral drug therapy.

The average incidence rate of Bell’s palsy was found to be 25.7 cases per 100,000 per year in the Qurayyat region of Saudi Arabia. The most affected age group comprised those aged 21–30 years, with females being 6.12 times more likely to be affected than males. Physiotherapy and standard drug therapy (corticosteroid and antiviral drugs) were preferred over the other modes of treatment. A study conducted in the Arar region of Saudi Arabia found 26.3% of cases of Bell’s palsy with females (61%) more affected than males (Alanazi et al., 2017) and that participants preferred physiotherapy treatment over drug therapy (Alanazi et al., 2017).

Most (75%) of the participants with Bell’s palsy experienced sudden facial muscle paralysis, with the majority having experienced first-time facial paralysis and 10.5% reporting recurrent facial paralysis. A study conducted in the Asir region of Saudi Arabia Bell’s reported a 5.35 per 100,000 population per year incidence rate of Bell’s palsy, with most patients reporting sudden onset Bell’s palsy in winter (Al Ghamdi, 1997). In contrast, the incidence rate of Bell’s palsy in our study was approximately 25.7 per 100,000 per year. The incidence rate was calculated based on the total population of the Qurayyat region, which was 180,430, according to the 2020 population census (Ministry of Health Saudi Arabia, 2020).

In our study, we found that 12.3% of participants reported Bell’s palsy after the COVID-19 vaccination. Research on the association of Bell’s palsy with the COVID-19 vaccination is scarce, with few case reports having been presented. Some studies have reported a significant association between COVID-19 vaccination and the incidence rate of Bell’s palsy (Cirillo & Doan, 2021); however, it is possible that these studies introduced selection bias in terms of age groups vaccinated, as the incidence rate of Bell’s palsy varies greatly with age (Li et al., 2021). In our study, we found that 78.9% of participants reported Bell’s palsy after being exposed to cold air. However, only 28.7% and 19.3% of participants reported having had a common cold or flu before suffering from Bell’s palsy. A study conducted among 1,181 active duty military service members in the United States reported a 33% higher incidence rate of Bell’s palsy in cold climates than in warm regions (Campbell & Brundage, 2002).

Pre-existing conditions, such as diabetes, middle ear infection, head injury, high blood pressure, head and neck surgery, stroke, genetic disease, neurological disorders, or respiratory disease were reported by a small number of participants with Bell’s palsy. A case-control study conducted in Italy among 381 cases reported no significant difference due to the presence of hypertension or diabetes. However, the likelihood of Bell’s palsy increased linearly every year by 2% with age (Monini et al., 2010).

Research has recommended allopathic drug therapy following Bell’s palsy (de Almeida et al., 2014). The use of corticosteroids is recommended to avoid unsatisfactory patient outcomes, and antiviral drug therapy has an additive benefit (De Almeida et al., 2009). However, in our study, 64.3% of participants reported not taking the recommended drugs. A review study by Potterton (2015) recommended using corticosteroid therapy within 72 h of the onset of Bell’s palsy for a better outcome. In the current study physiotherapy and allopathic drug therapy following the onset Bell’s palsy among the participants were favored treatment choices. Complementary therapy, such as dry needling, was reported by 20.5% of participants. A study conducted among the general population (n = 420) found only 49.6% favored steroid treatment, while 54.7% favored traditional medicine (AlYahya, Al-Qernas & Al-Shaheen, 2018). A study conducted among dental students (n = 654) reported that only 39% favored corticosteroid therapy (Al Meslet et al., 2019). Traditional Saudi medicine and cauterization (hot iron rod) were used by 18.7% and 13.5% of participants, respectively. This traditional medicine is reported to cause severe burn injuries and complicated wounds (Aboushanab & AlSanad, 2019).

Conclusions

The incidence rate of Bell’s palsy was approximately 25.7 per 100,000 per year in the Qurayyat region of Saudi Arabia. Exposure to cold air and influenza were significant risk factors associated with Bell’s palsy. Females were predominantly affected by Bell’s palsy in the Qurayyat region of Saudi Arabia. Bell’s palsy was most common among those aged 21–30 years. The most favored treatment was physiotherapy following Bell’s palsy. The population in the Qurayyat region of Saudi Arabia needs to be educated about the potential benefits of combination therapy, rather than relying on complementary or traditional medicine alone, for improved patient outcomes.

Supplemental Information